What’s in a name: Agencies struggle to keep up with expanding drug space
With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.

With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.
The company plans to use AI algorithms in trials to boost efficiency in study progression, cost-cutting and data evaluations.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Genentech and NVIDIA enter generative AI-powered drug discovery deal
Daiichi Sankyo signs agreement with Japan to supply Covid-19 vaccine
COP27: Have we committed to our goals?
Almirall and Absci partner on AI-driven dermatological drug development